Salud financiera de hoja de balance de Stepan
Salud financiera controles de criterios 4/6
Stepan tiene un patrimonio de accionistas total de $1.2B y una deuda total de $647.4M, lo que sitúa su ratio deuda-patrimonio en 53.4%. Sus activos y pasivos totales son $2.4B y $1.2B respectivamente. El BAIT de Stepan es de $80.3M, por lo que su ratio de cobertura de intereses es de 3.6. Tiene efectivo e inversiones a corto plazo que ascienden a $113.7M.
Información clave
53.41%
Ratio deuda-patrimonio
US$647.35m
Deuda
| Ratio de cobertura de intereses | 3.6x |
| Efectivo | US$113.71m |
| Patrimonio | US$1.21b |
| Total pasivo | US$1.18b |
| Activos totales | US$2.39b |
Actualizaciones recientes sobre salud financiera
Recent updates
Artículo de análisis • Aug 08
Results: Stepan Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Stepan Company ( NYSE:SCL ) defied analyst predictions to release its second-quarter results, which were ahead of...
Actualización de narrativa • Aug 07
SCL: Higher Margin Assumptions Will Support Long-Term Dividend Upside
Analysts have raised their price target for Stepan from $75 to $85, citing updated assumptions that include a lower discount rate, an increased profit margin of 10.80%, and a more conservative future P/E of 8.05x. What’s in the News for Stepan Stepan Company was added to the Russell 2000 Dynamic Index as an index constituent.Seeking Alpha • Jul 10
Stepan Company's Discount Isn't Over Yet
Summary Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next. SCL’s strategy focuses on expanding share in large, growing addressable markets across Surfactants and Polymers, supporting long-term upside. Read the full article on Seeking AlphaActualización de narrativa • Jun 18
SCL: Stable Margins And Outlook Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75, citing largely unchanged assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the basis for this reaffirmed view. What’s in the News for Stepan No recent Stepan news items were identified in the provided primary news source.Actualización de narrativa • Jun 04
SCL: Higher Margins And Revenue Outlook Will Support Long-Term Dividend Upside
Analysts have raised their price target for Stepan to $75.00, with the shift supported by updated assumptions for slightly lower discount rates, expectations of higher revenue, stronger profit margins, and a reduced future P/E multiple. What's in the News No recent company specific news items, periodical coverage, or key developments were provided for Stepan in the supplied sources.Actualización de narrativa • Apr 28
SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside
Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.Actualización de narrativa • Apr 12
SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside
Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).Actualización de narrativa • Mar 28
SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.Actualización de narrativa • Mar 14
SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside
Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.Actualización de narrativa • Feb 27
SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside
Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.Actualización de narrativa • Feb 11
SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside
Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.Artículo de análisis • Feb 04
Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge
Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...Actualización de narrativa • Jan 27
SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns
Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.Artículo de análisis • Jan 08
Stepan (NYSE:SCL) May Have Issues Allocating Its Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Artículo de análisis • Dec 12
Why Stepan Company (NYSE:SCL) Could Be Worth Watching
Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...Artículo de análisis • Nov 04
Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395
Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...Artículo de análisis • Sep 04
Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Artículo de análisis • Jul 31
Is It Time To Consider Buying Stepan Company (NYSE:SCL)?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Artículo de análisis • Jun 10
Earnings Tell The Story For Stepan Company (NYSE:SCL)
Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...Artículo de análisis • May 02
Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates
A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...Seeking Alpha • Apr 20
Stepan Company's Plunge Offers Investors A Chance To Clean Up
Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking AlphaArtículo de análisis • Apr 16
Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?
While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...Seeking Alpha • Feb 04
Stepan Company: A 'Moderate Buy' Despite A High Valuation
Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking AlphaArtículo de análisis • Jan 18
Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price
With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...Artículo de análisis • Nov 26
These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Artículo de análisis • Nov 02
Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's
The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...Seeking Alpha • Oct 30
Stepan Company: Not A Great Performance, But Good Value
Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking AlphaAnálisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($974.8M) de SCL superan a sus pasivos a corto plazo ($847.0M).
Pasivo a largo plazo: Los activos a corto plazo de SCL ($974.8M) superan a sus pasivos a largo plazo ($333.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de SCL (44%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de SCL ha crecido de 22.7% a 53.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de SCL está bien cubierta por el flujo de caja operativo (24%).
Cobertura de intereses: Los pagos de intereses de la deuda de SCL están bien cubiertos por el BAIT (3.6x cobertura).
Hoja de balance
Descubre empresas con salud financiera
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/09/10 06:06 |
| Precio de las acciones al final del día | 2026/09/10 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Stepan Company está cubierta por 4 analistas. 2 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Michael Harrison | Seaport Research Partners |
| Daniel Rizzo | Sidoti & Company, LLC |
| Vincent Anderson | Stifel, Equities Research |